Imricor Medical Systems Analyst Sees Buying Opportunity After Stock Drop

Morgans suggests that the over 20% fall in Imricor Medical Systems' share price since its entry into the ASX 300 index in early September presents a significant buying opportunity for investors. The stock closed Wednesday at A$1.585, down from a high of A$2.07 in August.